Results 291 to 300 of about 304,001 (345)

QSOX2‐Mediated Disulfide Bond Modification Enhances Tumor Stemness and Chemoresistance by Activating TSC2/mTOR/c‐Myc Feedback Loop in Esophageal Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
High QSOX2 enhances stemness, drug resistance, and metastasis of ESCC cells. QSOX2‐mediated disulfide bond modification activates mTOR/c‐Myc signaling. CAFs‐secreted IGF‐1 drives mTOR/c‐Myc/QSOX2 positive feedback loop. Combining Ebselen, rapamycin, and cisplatin induces tumor dormancy in mice.
Wo‐Ming Chen   +12 more
wiley   +1 more source

3D Brain Vascular Niche Model Captures Glioblastoma Infiltration, Dormancy, and Gene Signatures

open access: yesAdvanced Science, EarlyView.
This study developed a 3D brain vascular niche model that capture the key features of glioblastoma including perivascular infiltration, gene signature, dormancy and chemo resistance, by comparing 3D model with in vivo condition using identical glioma stem cells.
Vivian K. Lee   +10 more
wiley   +1 more source

Extracellular vesicles adhere to cells primarily by interactions of integrins and GM1 with laminin. [PDF]

open access: yesJ Cell Biol
Isogai T   +11 more
europepmc   +1 more source

Reinforcing Stromal Cell Spheroid Through Red‐Light Preconditioning for Advanced Vascularization

open access: yesAdvanced Science, EarlyView.
This study presents a novel approach to enhance stromal cell therapy for myocardial infarction by combining OLED‐based photobiomodulation (OPBM) preconditioning with 3D spheroid culture of hADSCs. The engineered spheroids improve angiogenesis, arterialization, and cardiac function in vivo, offering a next‐generation therapeutic strategy to overcome ...
Yu‐Jin Kim   +12 more
wiley   +1 more source

The immune response against cancer is modulated by stromal cell fibronectin. [PDF]

open access: yesNeoplasia
Lubosch A   +8 more
europepmc   +1 more source

Mechanical signaling regulates vascular smooth muscle cell adaptation in aging. [PDF]

open access: yesFront Physiol
Mohajeri A   +8 more
europepmc   +1 more source

Vedolizumab: Beyond Inflammatory Bowel Disease. [PDF]

open access: yesMed Princ Pract
Li Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy